HUMAN TUBERCULOSIS VACCINE MARKET ANALYSIS

Human Tuberculosis Vaccine Market, By Type (Live attenuated vaccine, Inactivated, and Others), By Age Group (Pediatrics and Adults), By Distribution Channel (Private and Public), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Nov 2024
Code : CMI5209
Pages :197
Formats :
Excel and PDF
Industry : Pharmaceutical

Key Takeaways from Analyst

The human tuberculosis vaccine market is expected to see steady growth over the forecast period driven by the rising prevalence of tuberculosis globally.

Asia Pacific is projected to continue dominating the market attributed to high TB burden countries including India and China present in the region. However, Africa is anticipated to emerge as the fastest growing regional market supported by increasing government focus on TB immunization programs across countries.

While vaccines have shown effectiveness in eliminating several deadly diseases, development of a strong vaccine for tuberculosis remains a challenge posed by the complexity of Mycobacterium tuberculosis. This constitutes a key restraint to rapid market expansion.